Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle G Goveia

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|August 6, 2010
RotaTeq: Progress toward developing world accessMichelle G Goveia, Christopher B Nelson, Max Ciarlet
Vaccine|September 20, 2021
Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling studyElamin H Elbasha, Yoonyoung Choi, Vince Daniels, et al.
Human Vaccines & Immunotherapeutics|August 25, 2017
Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccineG Frank Liu, Darcy Hille, Susan S Kaplan, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccineMichelle G Goveia, Max Ciarlet, Katey E Owen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2008
The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccinePenelope H Dennehy, Michelle G Goveia, Michael J Dallas, et al.
The Journal of Infectious Diseases|August 10, 2005
Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritisPenny M Heaton, Michelle G Goveia, Jacqueline M Miller, et al.
Vaccine: X|February 1, 2021
Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2T Christopher Mast, David Heyman, Erik Dasbach, et al.
Journal of the Pediatric Infectious Diseases Society|August 10, 2016
Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for VaccinationBerhanu G Gebremeskel, Dongmu Zhang, Michelle G Goveia, et al.
Vaccine|January 4, 2012
Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic reviewKosuke Kawai, Megan A O'Brien, Michelle G Goveia, et al.
The Pediatric Infectious Disease Journal|June 4, 2008
Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|August 6, 2010
RotaTeq: Progress toward developing world accessMichelle G Goveia, Christopher B Nelson, Max Ciarlet
Vaccine|September 20, 2021
Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling studyElamin H Elbasha, Yoonyoung Choi, Vince Daniels, et al.
Human Vaccines & Immunotherapeutics|August 25, 2017
Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccineG Frank Liu, Darcy Hille, Susan S Kaplan, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccineMichelle G Goveia, Max Ciarlet, Katey E Owen, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2008
The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccinePenelope H Dennehy, Michelle G Goveia, Michael J Dallas, et al.
The Journal of Infectious Diseases|August 10, 2005
Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritisPenny M Heaton, Michelle G Goveia, Jacqueline M Miller, et al.
Vaccine: X|February 1, 2021
Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2T Christopher Mast, David Heyman, Erik Dasbach, et al.
Journal of the Pediatric Infectious Diseases Society|August 10, 2016
Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for VaccinationBerhanu G Gebremeskel, Dongmu Zhang, Michelle G Goveia, et al.
Vaccine|January 4, 2012
Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic reviewKosuke Kawai, Megan A O'Brien, Michelle G Goveia, et al.
The Pediatric Infectious Disease Journal|June 4, 2008
Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequencyMichelle G Goveia, Mark J DiNubile, Michael J Dallas, et al.
Pageof 4